Cronus Pharma LLC, headquartered in East Brunswick, is launching products in the U.S. market and seeking FDA approval.
1 report, 1 independent
Updated Aug 26
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Cronus Pharma LLC, headquartered in East Brunswick, is launching products in the U.S. market and seeking FDA approval.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
- FDA
-
East Brunswick
township in Middlesex County, New Jersey, United States
Nothing else this week.
Related events
- UroGen Pharma Ltd., headquartered in Princeton, is seeking FDA approval for its products for the U.S. market.
- A product was launched in the U.S. market following FDA involvement.
- FDA approves products sold in Wisconsin stores, with business operations centered in Northeast Wisconsin.
- Anteris Technologies Global Corp. utilizes FDA-cleared technology and traded on NASDAQ, maintaining a presence in Minneapolis.
- Mylan is seeking regulatory approval from the FDA for new products and has listed its stock on the Nasdaq exchange.